Email updates

Keep up to date with the latest news and content from BMC Neuroscience and BioMed Central.

This article is part of the supplement: Seventeenth Annual Computational Neuroscience Meeting: CNS*2008

Open Access Poster presentation

Assessment of tamoxifen effects on nitric oxide synthase (nNOS) in rat developing hippocampus

Maliheh Nobakht1*, Maasoumeh Shafiee2 and Parvaneh Tabatabaeei1

Author Affiliations

1 Department of Anatomy, Histology and Neuroscience, School of Medicine, Iran University of Medical Science, 14155-6183 Tehran, Iran

2 Department of Pharmacology, School of Medicine, University of Medical Science, 14155-6183 Tehran, Iran

For all author emails, please log on.

BMC Neuroscience 2008, 9(Suppl 1):P64  doi:10.1186/1471-2202-9-S1-P64


The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2202/9/S1/P64


Published:11 July 2008

© 2008 Nobakht et al; licensee BioMed Central Ltd.

Background

Maternal steroids modulate various functions in the developing brain. Tamoxifen (TAM) treatment, as an estrogen antagonist, induced cell death in the rat developing hippocampus. Estrogen has a variety of physiological effects in the nervous system, including regulation of cognitive functions, learning, aging, angiogenesis and neurogenesis as well as neuroprotective effects.

Aim

In the present study, we demonstrated the effects of TAM as an estrogen antagonist on nitric oxide synthase activity in the rat developing hippocampus pyramidal neurons.

Materials and methods

The present description is based on twelve adult rats. The animals were divided randomly into control, experimental and sham groups. In each, we have full term embryo (E22), 1 day neonate (P1), one week neonate (P7) and three weeks neonate (P21). In experimental groups animals at full term received four doses of the (250 μg/kg in propylene glycol i.p. twice a day for a total of four doses). The hippocampus was removed 6 hours after the last injection. Animals at the same gestational age were used as sham and controls. Controls received only propylene glycol. The hippocampus was dissected out and stored in fixative and sucrose. Cryostat sections were thaw-mounted on gelatin slides. The sections were incubated for NADPH-diaphorase histochemistry by light microscopy.

Results

We found that in the earliest stage of development the cellular density is low and there was a gradual increase in cellular thickness, with maximum thickness observed after third weeks. The short half-life of tamoxifen can change E22, P1 and P7. The effect of treatment without tamoxifen, due to existence of estrogen, is characterized by strong NADPH-diaphorase activity that showed NOS activity. With treatment with tamoxifen, in the early stages, we found significant decreases in NADPH-diaphorase reactivity following estrogen receptor blockade. Furthermore, we demonstrated a decreased activity of NOS in the CA1 hippocampal region and reduced neuronal cell numbers. The decreased activity of NOS and reduced hippocampal cell numbers were observed in E22 and one day neonate and one week neonate.

Conclusion

Evidence so far suggests that this phenomenon may be the result of the short half-life of tamoxifen. These findings indicate that estrogen and selective estrogen modulators can influence nitric oxide-mediated growth and development in pyramidal cells.